(Reuters) - Botox maker AbbVie Inc's Allergan unit has accused Revance Therapeutics Inc in a federal lawsuit of poaching key employees in a "desperate" effort to compete in the market for anti-wrinkle ...
U.S. District Judge Eli Richardson in Nashville, Tennessee, ruled, opens new tab that Allergan plausibly alleged that Revance had acquired and used some of its rival’s trade secrets amid a series of ...
When Irvine drug maker Allergan Inc. reported its first-quarter results, Chief Executive David Pyott mentioned that it’s gotten two-thirds of commercial insurance plans to cover Botox injections to ...
A Virginia federal court jury has ordered Irvine drug maker Allergan Inc. to pay $212 million to a man who said he got permanent brain damage after being injected with Botox to treat cramps and ...
–All primary and secondary endpoints were met for second Phase 3 study (M21-310) and results were consistent with findings from first Phase 3 study (M21-309). –Results support onabotulinumtoxinA as a ...
IRVINE, Calif. (CBS.MW) -- Shares of Allergan jumped 6 percent Monday after the specialty pharmaceutical company announced it won a highly anticipated regulatory approval to market its Botox drug as a ...
IRVINE, Calif., Nov. 7, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that the sixth annual BOTOX® Cosmetic Day will be Wednesday, November 20. This holiday ...
Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback